The Association for Clinical Oncology is evaluating the Administration’s 2026 budget proposal, expressing concerns about the substantial cuts to federal health agencies, particularly the proposed 40% cut to the National Institutes of Health (NIH) budget. Dr. Eric P. Winer of ASCO emphasizes the potential detrimental impact on medical research and innovation, including cancer care, due to reduced funding and organizational changes. The proposed cuts to NIH and CDC could hinder vital research, screening programs, and prevention efforts, ultimately impacting cancer treatment and patient outcomes.